- In November 2022, Boston Scientific Corporation, a global leader in healthcare, announced its acquisition of Apollo Endosurgery, a U.S.-based medical technology company. This strategic acquisition enhances Boston Scientific’s capabilities in endoluminal surgery and provides entry into the emerging endo-bariatric market. The move expands the company's portfolio, positioning it to offer innovative solutions in weight-loss surgery and minimally invasive treatments
- In November 2022, Arthrex, Inc. and Richard Wolf formed a U.S.-based partnership to provide an integrated technology and product portfolio for urology, gynecology, and general surgery. This collaboration includes advanced features such as 4K image clarity with fluorescence imaging, operating room integration, specialized manual instruments, and flexible imaging. The launch of these comprehensive fluid management solutions enhanced both companies’ product portfolios and contributed to increased business revenue by offering more advanced and efficient solutions to healthcare providers
- In January 2021, STERIS plc announced its acquisition of Cantel Medical Corp through a U.S. subsidiary, solidifying its position in the infection prevention sector. Cantel, known for providing infection control products and services to endoscopy and dental sectors, broadened STERIS's portfolio. This strategic acquisition enabled STERIS to expand its global reach, enhance its customer base, and strengthen its presence in the infection prevention market, particularly in endoscopy solutions
- In January 2021, Olympus Corporation revealed it had reached an agreement to acquire Quest Photonic Devices B.V. for up to EUR 50 million, including milestone payments. This acquisition was aimed at enhancing Olympus's surgical endoscopy capabilities by integrating Quest’s advanced technologies. The move is expected to bolster Olympus's position in the endoscopy market and expand its product offerings, particularly in surgical applications
- In September 2021, Stryker announced its acquisition of Gauss Surgical, the developer of Triton™, an AI-powered platform for real-time blood loss monitoring during surgery. Triton has proven to enhance maternal and surgical care by enabling earlier detection of hemorrhage, leading to quicker intervention. This acquisition strengthens Stryker’s capabilities in improving patient outcomes through advanced technology in surgical environments
